Home / U.S. / U.S. Health

U.S. Health

Scientists tout positive findings in peanut allergy pill study

Scientists in Australia are reporting successful preliminary trials for a pill filled with a mix of probiotics and tiny amounts of peanut to build tolerance to peanut allergies. Study author Dr. Mimi Tang told the medical journal Lancet Child and A New Therapy May Cure Kids of Peanut Allergy Published …

Linwood, Philadelphia men agree to plea deals in federal drug fraud case

CAMDEN — A pharmaceutical representative from Linwood and a Philadelphia man agreed to a plea deals Thursday in connection with an ongoing federal investigation into a alleged multi-million dollar prescription drug benefits fraud case. Matthew …Linwood drug rep, Philly man plead guilty in $28M Shore public benefit Rx scheme Published By …

Could Urban Lighting Raise Breast Cancer Risk for Some Women?

THURSDAY, Aug. 17, 2017 (HealthDay News) — New research reveals an unexpected potential risk factor for breast cancer: city lights. The Harvard Medical School study found an association between living in areas with high amounts of ambient nighttime …Vaginal estrogens do not affect cancer, cardiovascular event risk Published By Google world …

FDA OKs Pfizer Drug for Rare, Fast-Killing Type of Leukemia

FDA approves new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. Aug. 17, 2017, at 5:35 p.m.. MORE. LinkedIn · StumbleUpon · Google +; Cancel. FDA OKs Pfizer Drug for Rare, Fast-Killing Type of …FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL Published By Google …

Woman bitten by rabid bat near Waterloo

The public is encouraged to not handle bats, especially if they appear to be acting unusual, such as flopping around on the ground. About 10 percent of bats are rabies carriers. Centers for Disease Control. breaking top story …Rabid Bat Found In Crestwood Published By Google world news 17 August 2017 …

FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL

The US Food and Drug Administration (FDA) today approved inotuzumab ozogamicin (Besponsa, Wyeth/Pfizer) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). “For adult patients with B-cell ALL …FDA approves Pfizer’s drug for rare blood cancer Published By Google world news 17 August 2017 8:18 …

Could Urban Lighting Raise Breast Cancer Risk for Some Women?

THURSDAY, Aug. 17, 2017 (HealthDay News) — New research reveals an unexpected potential risk factor for breast cancer: city lights. The Harvard Medical School study found an association between living in areas with high amounts of ambient nighttime …Outdoor light exposure at night may increase breast cancer risk: study Published By …